Literature DB >> 11209044

Can mosaic tumor vessels facilitate molecular diagnosis of cancer?

J Folkman1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11209044      PMCID: PMC33361          DOI: 10.1073/pnas.98.2.398

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  22 in total

Review 1.  The human genome project and the future of diagnostics, treatment, and prevention.

Authors:  G J van Ommen; E Bakker; J T den Dunnen
Journal:  Lancet       Date:  1999-07       Impact factor: 79.321

2.  Endothelial progenitor cells as putative targets for angiostatin.

Authors:  H Ito; I I Rovira; M L Bloom; K Takeda; V J Ferrans; A A Quyyumi; T Finkel
Journal:  Cancer Res       Date:  1999-12-01       Impact factor: 12.701

Review 3.  Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization.

Authors:  J M Isner; T Asahara
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

4.  Horizontal transfer of DNA by the uptake of apoptotic bodies.

Authors:  L Holmgren; A Szeles; E Rajnavölgyi; J Folkman; G Klein; I Ernberg; K I Falk
Journal:  Blood       Date:  1999-06-01       Impact factor: 22.113

5.  Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis.

Authors:  M Streit; L Riccardi; P Velasco; L F Brown; T Hawighorst; P Bornstein; M Detmar
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

6.  Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts.

Authors:  D Lyden; A Z Young; D Zagzag; W Yan; W Gerald; R O'Reilly; B L Bader; R O Hynes; Y Zhuang; K Manova; R Benezra
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

7.  Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.

Authors:  M S O'Reilly; T Boehm; Y Shing; N Fukai; G Vasios; W S Lane; E Flynn; J R Birkhead; B R Olsen; J Folkman
Journal:  Cell       Date:  1997-01-24       Impact factor: 41.582

8.  Openings between defective endothelial cells explain tumor vessel leakiness.

Authors:  H Hashizume; P Baluk; S Morikawa; J W McLean; G Thurston; S Roberge; R K Jain; D M McDonald
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

9.  Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization.

Authors:  T Takahashi; C Kalka; H Masuda; D Chen; M Silver; M Kearney; M Magner; J M Isner; T Asahara
Journal:  Nat Med       Date:  1999-04       Impact factor: 53.440

10.  Evidence for circulating bone marrow-derived endothelial cells.

Authors:  Q Shi; S Rafii; M H Wu; E S Wijelath; C Yu; A Ishida; Y Fujita; S Kothari; R Mohle; L R Sauvage; M A Moore; R F Storb; W P Hammond
Journal:  Blood       Date:  1998-07-15       Impact factor: 22.113

View more
  13 in total

Review 1.  Molecular imaging with nanoparticles: giant roles for dwarf actors.

Authors:  Paul Debbage; Werner Jaschke
Journal:  Histochem Cell Biol       Date:  2008-09-30       Impact factor: 4.304

2.  Metronomic chemotherapy in combination with antiangiogenic treatment induces mosaic vascular reduction and tumor growth inhibition in hepatocellular carcinoma xenografts.

Authors:  Fan Zhou; Juan Hu; Jiang-Hua Shao; Shu-Bing Zou; Shun-Li Shen; Zhi-Qiang Luo
Journal:  J Cancer Res Clin Oncol       Date:  2012-06-27       Impact factor: 4.553

3.  Anti-angiogenesis effect on glioma of attenuated Salmonella typhimurium vaccine strain with flk-1 gene.

Authors:  Keke Feng; Hongyang Zhao; Jian Chen; Dongxiao Yao; Xiaobing Jiang; Wei Zhou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

4.  Profiling bladder cancer using targeted antibody arrays.

Authors:  Marta Sanchez-Carbayo; Nicholas D Socci; Juan Jose Lozano; Brian B Haab; Carlos Cordon-Cardo
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

5.  Glioma stem/progenitor cells contribute to neovascularization via transdifferentiation.

Authors:  Jun Dong; Yaodong Zhao; Qiang Huang; Xifeng Fei; Yi Diao; Yuntian Shen; Hong Xiao; Tianyi Zhang; Qing Lan; Xiaosong Gu
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

6.  Prognostic significance and mechanisms of patterned matrix vasculogenic mimicry in hepatocellular carcinoma.

Authors:  Wen-bin Liu; Ge-liang Xu; Wei-dong Jia; Jian-sheng Li; Jin-liang Ma; Ke Chen; Zhi-hua Wang; Yong-sheng Ge; Wei-hua Ren; Ji-hai Yu; Wei Wang; Xiu-Jun Wang
Journal:  Med Oncol       Date:  2010-10-19       Impact factor: 3.064

7.  ARK5 is a tumor invasion-associated factor downstream of Akt signaling.

Authors:  Atsushi Suzuki; Jie Lu; Gen-Ichi Kusakai; Atsuhiro Kishimoto; Tsutomu Ogura; Hiroyasu Esumi
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

8.  Tailoring the lipid composition of nanoparticles modulates their cellular uptake and affects the viability of triple negative breast cancer cells.

Authors:  Hanan Abumanhal-Masarweh; Dana da Silva; Maria Poley; Assaf Zinger; Evgenya Goldman; Nitzan Krinsky; Ron Kleiner; Gal Shenbach; Josh E Schroeder; Jeny Shklover; Janna Shainsky-Roitman; Avi Schroeder
Journal:  J Control Release       Date:  2019-06-22       Impact factor: 9.776

9.  Sodium bicarbonate nanoparticles modulate the tumor pH and enhance the cellular uptake of doxorubicin.

Authors:  Hanan Abumanhal-Masarweh; Lilach Koren; Assaf Zinger; Zvi Yaari; Nitzan Krinsky; Galoz Kaneti; Nitsan Dahan; Yael Lupu-Haber; Edith Suss-Toby; Esther Weiss-Messer; Michal Schlesinger-Laufer; Janna Shainsky-Roitman; Avi Schroeder
Journal:  J Control Release       Date:  2019-01-05       Impact factor: 9.776

10.  Glucose restriction induces cell death in parental but not in homeodomain-interacting protein kinase 2-depleted RKO colon cancer cells: molecular mechanisms and implications for tumor therapy.

Authors:  A Garufi; A Ricci; D Trisciuoglio; E Iorio; G Carpinelli; G Pistritto; M Cirone; G D'Orazi
Journal:  Cell Death Dis       Date:  2013-05-23       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.